• 首页
  • 期刊简介
  • 编委会
    第六届编委会
  • 投稿须知
    文章要求
    投稿指南
    发表学术论文“五不准”
  • 本刊稿约
  • 期刊公告
  • 联系我们
引用本文:
【打印本页】   【下载PDF全文】     【下载PDF阅读器】  【关闭】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 5251次   下载 0次 本文二维码信息
码上扫一扫!
替米沙坦联合硝苯地平对EH患者的疗效及对血清中HGF、VEGF水平变化的影响
吕昌;王康梅;陈文思;
广东省妇幼保健院药学部
摘要:
目的分析替米沙坦联合硝苯地平对原发性高血压(EH)患者的治疗效果及对血清肝细胞生长因子(HGF)、血管内皮生长因子(VEGF)水平的影响。方法回顾性选取2014年11月至2016年10月我院收治的原发性高血压患者98例,根据治疗方法不同分为对照组和观察组。对照组患者采用硝苯地平治疗,观察组患者采用替米沙坦联合硝苯地平治疗。观察并比较两组患者疗效、超声心动图指标水平、脂联素、细胞间黏附分子-1(ICAM-1)、HGF、VEGF水平及血管弹性指标水平变化情况。结果观察组患者总有效率为92.88%,对照组为79.60%,观察组总有效率高于对照组,差异有统计学意义(P<0.05)。两组患者治疗后LVPWT、LVEDD及IVMI水平均较治疗前改善,观察组患者治疗后LVPWT、LVEDD及IVMI水平优于对照组,差异有统计学意义(P<0.05)。两组患者治疗后脂联素水平较治疗前上升,ICAM-1、HGF及VEGF水平均较治疗前下降,观察组患者治疗后脂联素水平高于对照组,ICAM-1、HGF及VEGF水平低于对照组,差异有统计学意义(P<0.05)。两组患者治疗后C1、C2及PWV水平均较治疗前改善,观察组患者治疗后C1、C2及PWV水平均优于对照组,差异有统计学意义(P<0.05)。结论替米沙坦联合硝苯地平治疗原发性高血压疗效确切,可改善患者左心室构造和血管弹性,降低血清HGF、VEGF水平。
关键词:  替米沙坦  硝苯地平  原发性高血压  肝细胞生长因子  左心室构造
DOI:
分类号:
基金项目:
Effect of Telmisartan Combined with Nifedipine on EH Patients and Their Influence on Serum Levels of HGF and VEGF
Lv Chang;Wang Kangmei;Chen Wensi
Department of Pharmacy,Guangdong Provincial Maternity and Child Health Care Center
Abstract:
Objective To analyze the effect of Telmisartan combined with Nifedipine on the treatment of patients with essential hypertension( EH) and the influence on serum hepatocyte growth factor( HGF) and vascular endothelial growth factor( VEGF) levels.Methods 98 cases of essential hypertension patients received in our hospital during November 2014 to October2016 were selected retrospectively and divided into control group and observation group according to different therapeutic schemes.Patients in control group were treated with Nifedipine and patients in observation group were treated with Telmisartan combined with Nifedipine. The changes of therapeutic effect,indicators in echocardiography,adiponectin,intercellular adhesion molecule-1( ICAM-1),HGF,VEGF and vascular elasticity in the two groups were observed and compared.Results The overall response rate of observation group was 92. 88%,which is higher than 79. 60% of control group,the difference being statistically significant( P<0. 05).LVPWT,LVEDD and IVMI of patients in the two groups were both improved after treatment,and furthermore,post-treatment LVPWT,LVEDD and IVMI of observation group was superior to those of control group,the difference being statistically significant( P<0. 05).Adiponectin levels of the two groups rose and ICAM-1,HGF as well as VEGF levels fell after treatment,compared with conditions before treatment. Post-treatment adiponectin level of observation group was higher than that of control group and post-treatment ICAM-1,HGF as well as VEGF levels of observation group were lower than those of control group,the difference being statistically significant( P<0. 05).C1,C2 and PWV levels of the two groups were both improved after treatment and post-treatment C1,C2 and PWV levels of observation group were superior to those of control group,the difference being statistically significant( P<0. 05).Conclusion Telmisartan combined with Nifedipine is effective in the treatment of essential hypertension and can improve the left ventricular construction as well as vascular elasticity,reduce serum HGF and VEGF levels of patients.
Key words:  Telmisartan  Nifedipine  essentialhypertension  hepatocytegrowthfactor  leftventricularconstruction
您是本站第  91514676  位访问者!蜀ICP备11024768号
版权所有:(C)四川省医疗卫生服务指导中心 2010 CopyRight http://scmj.scyx.org.cn/ all right reserved.
地址:成都市玉林南街2号附3号   电话:028-86136765 邮编:610041
技术支持:北京勤云科技发展有限公司